Royalty Pharma plc
RPRX
Peringkat dalam Saham
#892
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Harga Saham
$60.39
Terakhir disinkronkan: 2026-10-19
Kapitalisasi Pasar
$26.89B
Perubahan (1 hari)
-0.93%
Perubahan (1 tahun)
64.87%
Negara
US
Perdagangan Royalty Pharma plc (RPRX)
Kategori
Healthcare
Riwayat hasil dividen untuk Royalty Pharma plc (RPRX)
Hasil dividen (TTM) dari Royalty Pharma plc (simbol saham: RPRX) per 2023-12-31: 2.85%
Rata-rata hasil dividen selama 5 tahun terakhir: 2.37%
Rata-rata hasil dividen selama 5 tahun terakhir: 2.37%
Riwayat hasil dividen untuk Royalty Pharma plc (RPRX) dari 2015 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
| Tahun | Hasil Dividen | Mengubah |
|---|---|---|
| 2026 (TTM) | 1.57% | -52.57% |
| 2024 | 3.31% | 16.14% |
| 2023 | 2.85% | 47.67% |
| 2022 | 1.93% | 11.56% |
| 2021 | 1.73% | -15.61% |
| 2020 | 2.05% | -56.29% |
| 2019 | 4.69% | -9.28% |
| 2018 | 5.17% | 10.94% |
| 2017 | 4.66% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
| Perusahaan | Hasil Dividen | Negara |
|---|---|---|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 2.29% |
HK
|
|
| 0.00% |
US
|
